High frequency chest wall oscillation (HFCWO) in the treatment of acute pulmonary exacerbation in adult cystic fibrosis (CF) patients Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children Year: 2013
Assessment of a new magnetic resonance imaging (MRI)-scoring- system for pulmonary changes in patients with cystic fibrosis (CF) – comparison with clinical parameters and high resolution computed tomography (HRCT) Source: Annual Congress 2006 - New modalities and application in imaging of the chest Year: 2006
Structure-function relationships in the lungs of cystic fibrosis (CF) patients using multi-volume high-resolution CT (HRCT) and proton MRI (1H-MRI) Source: International Congress 2016 – Lung function and imaging: new findings and new approaches Year: 2016
Multivolume magnetic resonance imaging (1H-MRI) for the longitudinal assessment of cystic fibrosis (CF) lung disease: comparison with spirometry Source: Virtual Congress 2020 – New frontiers in cystic fibrosis imaging and lung physiology Year: 2020
Hyperinflation in adult cystic fibrosis (CF) patients: Clinical and functional correlates Source: Annual Congress 2010 - Cystic fibrosis: clinical and laboratory studies Year: 2010
Comparison of high resolution computerized tomography (HRCT) of the chest and pulmonary function testing in evaluating the effect of tobramycin solution for inhalation in cystic fibrosis (CF) patients Source: Eur Respir J 2004; 24: Suppl. 48, 387s Year: 2004
Diagnostic and therapeutic difficulties in pulmonary aspergillosis (PA) in paediatric cystic fibrosis (CF) patients Source: Eur Respir J 2006; 28: Suppl. 50, 485s Year: 2006
Impact of bisphosphonate (BP) use on lung function decline and treatment response in patients (pts) with idiopathic pulmonary fibrosis (IPF) Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis Year: 2020
Progression of lung involvement in patients with cystic fibrosis (CF), assessed by longitudinal respiratory function measurements Source: Eur Respir J 2002; 20: Suppl. 38, 20s Year: 2002
Variability of the lung clearance index (LCI) assessed pre and post physiotherapy in patients with cystic fibrosis (CF) Source: Annual Congress 2008 - Clinical applications of ventilatory function tests in paediatric pulmonology Year: 2008
Changes in quantitative measures of airways on computed tomography (CT) in children with cystic fibrosis (CF) Source: Eur Respir J 2005; 26: Suppl. 49, 728s Year: 2005
Specific cystic fibrosis (CF) abnormalities studied by multi-volume CT and proton MRI (1H-MRI) Source: International Congress 2016 – Respiratory muscles and airways function: from physiology to clinical implications Year: 2016
CT scans from CF patients screened for lung transplant; the severe advanced lung disease (SALD) CT scoring system and correlation with survival Source: Annual Congress 2007 - Cystic fibrosis lung disease: from diagnosis to end-stage Year: 2007
Quantitative multivolume magnetic resonance imaging (1H-MRI) in patients with cystic fibrosis (CF) lung disease:comparison with FEV1 and lung clearance index (LCI) Source: International Congress 2017 – Cystic fibrosis: monitoring and biomarkers Year: 2017
Breathing pattern during rest and exercise in patients with cystic fibrosis (CF), pulmonary fibrosis (PF) and COPD before lung transplantation Source: Eur Respir J 2005; 26: Suppl. 49, 685s Year: 2005
High-resolution CT (HRCT) reflects disease progression in patients with idiopathic pulmonary fibrosis (IPF) Source: International Congress 2017 – The wide spectrum of ILDs Year: 2017
Role of chest magnetic resonance imaging (MRI) in the assessment and follow up of patients with cystic fibrosis (CF) Source: Annual Congress 2010 - Infection, inflammation and destruction Year: 2010
Ability of chest radiograph (CXR) scores and lung function tests to detect abnormalities in infants with cystic fibrosis (CF) Source: Eur Respir J 2005; 26: Suppl. 49, 405s Year: 2005
High resolution computed tomography (HRCT) findings before and after treatment with Interferon gamma - 1b (IFN-γ) or colchicine in idiopathic pulmonary fibrosis (IPF) patients Source: Eur Respir J 2003; 22: Suppl. 45, 592s Year: 2003
The potential of closed circuit lung clearance index (LCI) to provide longitudinal clinical utility in cystic fibrosis (CF). Source: International Congress 2019 – Physiology of cystic fibrosis Year: 2019